<DOC>
	<DOCNO>NCT02772341</DOCNO>
	<brief_summary>Background : Asthma chronic inflammatory disorder require intermittent continuous anti-inflammatory therapy . Patients often turn alternative treatment complement replacement conventional treatment . Aim : To evaluate effect salt room chamber ( halotherapy ) bronchial hyper- responsiveness ( BHR ) , fractional exhale nitric oxide ( FeNO ) , quality life child asthma . Patients : Children age 5-13 year clinical diagnosis mild asthma receive anti-inflammatory therapy . Methods : Randomized , double-blind , placebo-controlled study assess effect salt room therapy BHR , FeNO , spirometry pediatric asthma quality life questionnaire ( PAQLQ ) . The treatment period last 7 week , 14 session ( treatment group ) without salt halogenerator .</brief_summary>
	<brief_title>Evaluation Halotherapy Asthma Treatment Children</brief_title>
	<detailed_description>Asthma chronic inflammatory disorder require intermittent continuous anti-inflammatory therapy . Patients often turn alternative treatment complement replacement conventional treatment . Our aim : To evaluate effect salt room chamber ( halotherapy ) bronchial hyper - responsiveness ( BHR ) , fractional exhale nitric oxide ( FeNO ) , quality life child asthma . Patients : Children age 5-13 year clinical diagnosis mild asthma receive anti-inflammatory therapy . Methods : Randomized , double-blind , placebo-controlled study assess effect salt room therapy BHR , FeNO , spirometry pediatric asthma quality life questionnaire ( PAQLQ ) . The treatment period last 7 week , 14 session ( treatment group ) without salt halogenerator . Visit 1 : Written parental consent . Demographics , child 's asthma/atopy history , family history asthma/atopy/smoking . The Pediatric asthma quality life questionnaire ( PAQLQ ) patient/caregiver interviewer . Each patient perform spirometry , methacholine challenge test ( MCT ) FeNO measurement . Following positive MCT , patient randomize 14 session ( 7 week , twice weekly , 45 minute treatment ) sit salt room salt aerosol produce halogenerator ( study group ) halotherapy without salt aerosol ( placebo ) . Both wall ceiling salt room completely cover European Salt Company ( ESCO ) type certified-origin rock salt . The temperature ( 20-24°C ) humidity ( 44-60 % ) constant value . The halogenerator locate outside salt room . In study group , dry sodium chloride ( NaCl ) particle ( ~20μm ) blown salt room blower work without NaCl placebo group . The patient could tell dry salt aerosol generate halogenerator . The patient instruct use inhale β2beta agonist need report asthma exacerbation , use medication health care visit . Visit 2 : After seven week , patient re-evaluated spirometry , MCT , FeNO , PAQLQ .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>513 year Mild asthma Positive methacholine challenge test ( MCV , PC20FEV1 &lt; 16mg/ml ) Any Chronic Lung Disease Febrile Illness last 2 week FEV1 &lt; 65 % study day Bronchodilators past 24 hour prior study Participation clinical study past 4 week Any acute illness day MCT , Antiinflammatory treatment ( inhaled corticosteroid montelukast ) previous two week MCT ) . Systemic corticosteroid two month prior enrollment Emergency room ( ER ) visit hospital admission follow respiratory illness 2month period prior enrollment . Previous halotherapy treatment .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Halotherapy</keyword>
	<keyword>Airway hyper-reactivity</keyword>
	<keyword>Metacholine</keyword>
</DOC>